Evidence map›Paper›PMID 32002803›Full record

ArticleJournal of robotic surgery2020

Robotic-assisted radical cystectomy: the first multicentric Brazilian experience.

Marcio Covas Moschovas, Daher Cesar Chade, Marco Antonio Arap, Alvaro Sadek Sarkis, William Carlos Nahas, Luiz Henrique Rodrigues Tanure, Gustavo Ebaid, Arnaldo Jose de Carvalho Fazoli, Giuliano Betoni Guglielmetti, Carolina Bistacco and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marcio Covas MoschovasHospital 9 de Julho, São Paulo, Brazil. marcio.doc@hotmail.com.ORCID http://orcid.org/0000-0002-3290-7323
Daher Cesar ChadeInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Marco Antonio ArapHospital Sírio Libanês, São Paulo, Brazil.
Alvaro Sadek SarkisInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
William Carlos NahasInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Luiz Henrique Rodrigues TanureHospital 9 de Julho, São Paulo, Brazil.
Gustavo EbaidHospital das Clínicas, São Paulo, Brazil.
Arnaldo Jose de Carvalho FazoliInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Giuliano Betoni GuglielmettiInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Carolina BistaccoFaculdade de Medicina do ABC, São Paulo, Brazil.
Maurício CordeiroInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Paulo AfonsoInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.
Maria Chiara SighinolfiUniversity of Modena and Reggio Emilia, Modena, Italy.
Bernardo RoccoUniversity of Modena and Reggio Emilia, Modena, Italy.
Rafael Ferreira CoelhoInstituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to report the first multicentric Brazilian series and learning curve of robotic radical cystectomy (RARC) with related intra- and postoperative outcomes. We retrospectively analyzed 37 RARC prospectively collected at four different centers in Brazil, from 2013 to 2019. We analyzed the patient's demographics, pathological tumor, and nodal status, as well as intra- and postoperative outcomes. Statistical analysis was performed with the IBM (SPSS version 25) software. Overall, 86% were male, and the median age was 69 years. 83% had muscle-invasive bladder cancer, and 17% a high-grade, recurrent non-muscle-invasive tumor. The median operative time was 420 min with 300 min as console time. Median blood loss was 350 ml and transfusion rate was 10%. In 68% of the cases, we performed an intracorporeal Bricker urinary diversion, 24% intracorporeal neobladder, and 8% ureterostomy. Six patients (16%) had a Clavien 1-2, 8% had Clavien 3, 2.5% had a Clavien 4, and 5% had Clavien 5. The median length of hospital stay was 7 days. The final pathological exam pointed out pT0 in 16%, pT1 in 8%, pT2 in 32%, ≥ pT3 in 27%, and 16% pTis. 95% had negative surgical margins. The survival at 30, 90, and 180 days was 98%, 95%, and 95%, respectively. To our knowledge, this is the first multicentric series of RARC reporting the learning curve in Brazil; even if still representing a challenging procedure, RARC could be safely and effectively faced by experienced surgeons at centers with high volumes of robotic surgery.

Indexed as

AgedAged, 80 and overBlood Loss, SurgicalBrazilCystectomyFemaleHumansLength of StayMaleMiddle AgedNeoplasm StagingOperative TimeRetrospective StudiesRobotic Surgical ProceduresSurvival RateTreatment OutcomeBladder cancerRobotic-assisted radical cystectomyRobotic surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.